USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
The US Food and Drug Administration (USFDA) issues a Complete Response Letter (CRL) to convey to a company that its initial review…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.